Report Detail

Pharma & Healthcare Global Cold and Flu Drugs Market Size, Status and Forecast 2020-2026

  • RnM4019535
  • |
  • 10 June, 2020
  • |
  • Global
  • |
  • 93 Pages
  • |
  • QYResearch
  • |
  • Pharma & Healthcare

This report focuses on the global Cold and Flu Drugs status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Cold and Flu Drugs development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

The key players covered in this study
Reckitt Benckiser Group
Johnson & Johnson
GlaxoSmithKline
Novartis
Bayer
AstraZeneca
Sun Pharmaceutical Industries
Pfizer
Prestige Brands Holdings
Procter & Gamble

Market segment by Type, the product can be split into
Antihistamines
Expectorants
Bronchodilators
Decongestants
Antibiotics
Others
Market segment by Application, split into
OTC
Rx

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Cold and Flu Drugs status, future forecast, growth opportunity, key market and key players.
To present the Cold and Flu Drugs development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Cold and Flu Drugs are as follows:
History Year: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Year 2020 to 2026
For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.


1 Report Overview

  • 1.1 Study Scope
  • 1.2 Key Market Segments
  • 1.3 Players Covered: Ranking by Cold and Flu Drugs Revenue
  • 1.4 Market Analysis by Type
    • 1.4.1 Global Cold and Flu Drugs Market Size Growth Rate by Type: 2020 VS 2026
    • 1.4.2 Antihistamines
    • 1.4.3 Expectorants
    • 1.4.4 Bronchodilators
    • 1.4.5 Decongestants
    • 1.4.6 Antibiotics
    • 1.4.7 Others
  • 1.5 Market by Application
    • 1.5.1 Global Cold and Flu Drugs Market Share by Application: 2020 VS 2026
    • 1.5.2 OTC
    • 1.5.3 Rx
  • 1.6 Coronavirus Disease 2019 (Covid-19): Cold and Flu Drugs Industry Impact
    • 1.6.1 How the Covid-19 is Affecting the Cold and Flu Drugs Industry
      • 1.6.1.1 Cold and Flu Drugs Business Impact Assessment - Covid-19
      • 1.6.1.2 Supply Chain Challenges
      • 1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
    • 1.6.2 Market Trends and Cold and Flu Drugs Potential Opportunities in the COVID-19 Landscape
    • 1.6.3 Measures / Proposal against Covid-19
      • 1.6.3.1 Government Measures to Combat Covid-19 Impact
      • 1.6.3.2 Proposal for Cold and Flu Drugs Players to Combat Covid-19 Impact
  • 1.7 Study Objectives
  • 1.8 Years Considered

2 Global Growth Trends by Regions

  • 2.1 Cold and Flu Drugs Market Perspective (2015-2026)
  • 2.2 Cold and Flu Drugs Growth Trends by Regions
    • 2.2.1 Cold and Flu Drugs Market Size by Regions: 2015 VS 2020 VS 2026
    • 2.2.2 Cold and Flu Drugs Historic Market Share by Regions (2015-2020)
    • 2.2.3 Cold and Flu Drugs Forecasted Market Size by Regions (2021-2026)
  • 2.3 Industry Trends and Growth Strategy
    • 2.3.1 Market Top Trends
    • 2.3.2 Market Drivers
    • 2.3.3 Market Challenges
    • 2.3.4 Porter’s Five Forces Analysis
    • 2.3.5 Cold and Flu Drugs Market Growth Strategy
    • 2.3.6 Primary Interviews with Key Cold and Flu Drugs Players (Opinion Leaders)

3 Competition Landscape by Key Players

  • 3.1 Global Top Cold and Flu Drugs Players by Market Size
    • 3.1.1 Global Top Cold and Flu Drugs Players by Revenue (2015-2020)
    • 3.1.2 Global Cold and Flu Drugs Revenue Market Share by Players (2015-2020)
    • 3.1.3 Global Cold and Flu Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.2 Global Cold and Flu Drugs Market Concentration Ratio
    • 3.2.1 Global Cold and Flu Drugs Market Concentration Ratio (CR5 and HHI)
    • 3.2.2 Global Top 10 and Top 5 Companies by Cold and Flu Drugs Revenue in 2019
  • 3.3 Cold and Flu Drugs Key Players Head office and Area Served
  • 3.4 Key Players Cold and Flu Drugs Product Solution and Service
  • 3.5 Date of Enter into Cold and Flu Drugs Market
  • 3.6 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2015-2026)

  • 4.1 Global Cold and Flu Drugs Historic Market Size by Type (2015-2020)
  • 4.2 Global Cold and Flu Drugs Forecasted Market Size by Type (2021-2026)

5 Cold and Flu Drugs Breakdown Data by Application (2015-2026)

  • 5.1 Global Cold and Flu Drugs Market Size by Application (2015-2020)
  • 5.2 Global Cold and Flu Drugs Forecasted Market Size by Application (2021-2026)

6 North America

  • 6.1 North America Cold and Flu Drugs Market Size (2015-2020)
  • 6.2 Cold and Flu Drugs Key Players in North America (2019-2020)
  • 6.3 North America Cold and Flu Drugs Market Size by Type (2015-2020)
  • 6.4 North America Cold and Flu Drugs Market Size by Application (2015-2020)

7 Europe

  • 7.1 Europe Cold and Flu Drugs Market Size (2015-2020)
  • 7.2 Cold and Flu Drugs Key Players in Europe (2019-2020)
  • 7.3 Europe Cold and Flu Drugs Market Size by Type (2015-2020)
  • 7.4 Europe Cold and Flu Drugs Market Size by Application (2015-2020)

8 China

  • 8.1 China Cold and Flu Drugs Market Size (2015-2020)
  • 8.2 Cold and Flu Drugs Key Players in China (2019-2020)
  • 8.3 China Cold and Flu Drugs Market Size by Type (2015-2020)
  • 8.4 China Cold and Flu Drugs Market Size by Application (2015-2020)

9 Japan

  • 9.1 Japan Cold and Flu Drugs Market Size (2015-2020)
  • 9.2 Cold and Flu Drugs Key Players in Japan (2019-2020)
  • 9.3 Japan Cold and Flu Drugs Market Size by Type (2015-2020)
  • 9.4 Japan Cold and Flu Drugs Market Size by Application (2015-2020)

10 Southeast Asia

  • 10.1 Southeast Asia Cold and Flu Drugs Market Size (2015-2020)
  • 10.2 Cold and Flu Drugs Key Players in Southeast Asia (2019-2020)
  • 10.3 Southeast Asia Cold and Flu Drugs Market Size by Type (2015-2020)
  • 10.4 Southeast Asia Cold and Flu Drugs Market Size by Application (2015-2020)

11 India

  • 11.1 India Cold and Flu Drugs Market Size (2015-2020)
  • 11.2 Cold and Flu Drugs Key Players in India (2019-2020)
  • 11.3 India Cold and Flu Drugs Market Size by Type (2015-2020)
  • 11.4 India Cold and Flu Drugs Market Size by Application (2015-2020)

12 Central & South America

  • 12.1 Central & South America Cold and Flu Drugs Market Size (2015-2020)
  • 12.2 Cold and Flu Drugs Key Players in Central & South America (2019-2020)
  • 12.3 Central & South America Cold and Flu Drugs Market Size by Type (2015-2020)
  • 12.4 Central & South America Cold and Flu Drugs Market Size by Application (2015-2020)

13 Key Players Profiles

  • 13.1 Reckitt Benckiser Group
    • 13.1.1 Reckitt Benckiser Group Company Details
    • 13.1.2 Reckitt Benckiser Group Business Overview and Its Total Revenue
    • 13.1.3 Reckitt Benckiser Group Cold and Flu Drugs Introduction
    • 13.1.4 Reckitt Benckiser Group Revenue in Cold and Flu Drugs Business (2015-2020))
    • 13.1.5 Reckitt Benckiser Group Recent Development
  • 13.2 Johnson & Johnson
    • 13.2.1 Johnson & Johnson Company Details
    • 13.2.2 Johnson & Johnson Business Overview and Its Total Revenue
    • 13.2.3 Johnson & Johnson Cold and Flu Drugs Introduction
    • 13.2.4 Johnson & Johnson Revenue in Cold and Flu Drugs Business (2015-2020)
    • 13.2.5 Johnson & Johnson Recent Development
  • 13.3 GlaxoSmithKline
    • 13.3.1 GlaxoSmithKline Company Details
    • 13.3.2 GlaxoSmithKline Business Overview and Its Total Revenue
    • 13.3.3 GlaxoSmithKline Cold and Flu Drugs Introduction
    • 13.3.4 GlaxoSmithKline Revenue in Cold and Flu Drugs Business (2015-2020)
    • 13.3.5 GlaxoSmithKline Recent Development
  • 13.4 Novartis
    • 13.4.1 Novartis Company Details
    • 13.4.2 Novartis Business Overview and Its Total Revenue
    • 13.4.3 Novartis Cold and Flu Drugs Introduction
    • 13.4.4 Novartis Revenue in Cold and Flu Drugs Business (2015-2020)
    • 13.4.5 Novartis Recent Development
  • 13.5 Bayer
    • 13.5.1 Bayer Company Details
    • 13.5.2 Bayer Business Overview and Its Total Revenue
    • 13.5.3 Bayer Cold and Flu Drugs Introduction
    • 13.5.4 Bayer Revenue in Cold and Flu Drugs Business (2015-2020)
    • 13.5.5 Bayer Recent Development
  • 13.6 AstraZeneca
    • 13.6.1 AstraZeneca Company Details
    • 13.6.2 AstraZeneca Business Overview and Its Total Revenue
    • 13.6.3 AstraZeneca Cold and Flu Drugs Introduction
    • 13.6.4 AstraZeneca Revenue in Cold and Flu Drugs Business (2015-2020)
    • 13.6.5 AstraZeneca Recent Development
  • 13.7 Sun Pharmaceutical Industries
    • 13.7.1 Sun Pharmaceutical Industries Company Details
    • 13.7.2 Sun Pharmaceutical Industries Business Overview and Its Total Revenue
    • 13.7.3 Sun Pharmaceutical Industries Cold and Flu Drugs Introduction
    • 13.7.4 Sun Pharmaceutical Industries Revenue in Cold and Flu Drugs Business (2015-2020)
    • 13.7.5 Sun Pharmaceutical Industries Recent Development
  • 13.8 Pfizer
    • 13.8.1 Pfizer Company Details
    • 13.8.2 Pfizer Business Overview and Its Total Revenue
    • 13.8.3 Pfizer Cold and Flu Drugs Introduction
    • 13.8.4 Pfizer Revenue in Cold and Flu Drugs Business (2015-2020)
    • 13.8.5 Pfizer Recent Development
  • 13.9 Prestige Brands Holdings
    • 13.9.1 Prestige Brands Holdings Company Details
    • 13.9.2 Prestige Brands Holdings Business Overview and Its Total Revenue
    • 13.9.3 Prestige Brands Holdings Cold and Flu Drugs Introduction
    • 13.9.4 Prestige Brands Holdings Revenue in Cold and Flu Drugs Business (2015-2020)
    • 13.9.5 Prestige Brands Holdings Recent Development
  • 13.10 Procter & Gamble
    • 13.10.1 Procter & Gamble Company Details
    • 13.10.2 Procter & Gamble Business Overview and Its Total Revenue
    • 13.10.3 Procter & Gamble Cold and Flu Drugs Introduction
    • 13.10.4 Procter & Gamble Revenue in Cold and Flu Drugs Business (2015-2020)
    • 13.10.5 Procter & Gamble Recent Development

14 Analyst's Viewpoints/Conclusions

    15 Appendix

    • 15.1 Research Methodology
      • 15.1.1 Methodology/Research Approach
      • 15.1.2 Data Source
    • 15.2 Disclaimer

    Summary:
    Get latest Market Research Reports on Cold and Flu Drugs. Industry analysis & Market Report on Cold and Flu Drugs is a syndicated market report, published as Global Cold and Flu Drugs Market Size, Status and Forecast 2020-2026. It is complete Research Study and Industry Analysis of Cold and Flu Drugs market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $3,900.00
    $5,850.00
    $7,800.00
    3,112.20
    4,668.30
    6,224.40
    3,642.60
    5,463.90
    7,285.20
    609,453.00
    914,179.50
    1,218,906.00
    325,611.00
    488,416.50
    651,222.00
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report